![Nadège Pelletier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nadège Pelletier
Director Técnico/Científico/I+D en BARINTHUS BIOTHERAPEUTICS PLC .
Fortuna: - $ al 31/05/2024
Cargos activos de Nadège Pelletier
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BARINTHUS BIOTHERAPEUTICS PLC | Director Técnico/Científico/I+D | 01/02/2023 | - |
Historial de carrera de Nadège Pelletier
Antiguos cargos conocidos de Nadège Pelletier.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formación de Nadège Pelletier.
Université Claude Bernard Lyon 1 | Doctorate Degree |
École Normale Supérieure de Lyon | Graduate Degree |
Estadísticas
Internacional
Francia | 3 |
Reino Unido | 2 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Nadège Pelletier
- Experiencia